Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL133189 | 1.00 | ALDH1A1 (0.41) | ALDH1A1MEN1KMT2ANPSR1LMNA | |
| SCHEMBL1159030 | 1.00 | ALDH1A1 (0.41) | ALDH1A1MEN1KMT2ANPSR1LMNA | |
| SCHEMBL1931350 | 0.98 | ALDH1A1 (0.40) | ALDH1A1MEN1KMT2ANPSR1LMNA | |
| SCHEMBL5840557 | 0.98 | ALDH1A1 (0.40) | ALDH1A1MEN1KMT2ANPSR1LMNA | |
| Hydrochloric Acid SCHEMBL29639278 | 0.98 | ALDH1A1 (0.40) | ALDH1A1MEN1KMT2ANPSR1LMNA | |
| SCHEMBL33526641 | 0.98 | ALDH1A1 (0.40) | ALDH1A1MEN1KMT2ANPSR1LMNA | |
| SCHEMBL16694717 | 0.98 | GAA (0.39) | ALDH1A1MEN1KMT2ANPSR1LMNA | |
| SCHEMBL27516331 | 0.95 | ALDH1A1 (0.41) | ALDH1A1MEN1KMT2ANPSR1LMNA | |
| SCHEMBL19469297 | 0.95 | ALDH1A1 (0.38) | ALDH1A1MEN1KMT2ANPSR1LMNA | |
| Dimethylamine SCHEMBL645332 | 0.93 | ALDH1A1 (0.40) | ALDH1A1MEN1KMT2ANPSR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 640 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122010821-A | Adaglazecloth Synthesis method of intermediate | 上海博氏医药科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20250388564-A1 | METHODS OF MANUFACTURING PYRIDAZINONE COMPOUNDS | EDGEWISE THERAPEUTICS INC (US) | 2025-12-25 | — | — | US | claimed |
| EP-4649082-A1 | PREPARATION OF A TYK2 INHIBITOR | Ventyx Biosciences, Inc. (US) | 2025-11-19 | — | — | EP | claimed |
| CN-120189982-A | Composite catalyst and preparation method thereof, and method for preparing enol compound by reduction of alkynol compound | 山东新和成药业有限公司 | 2025-06-24 | — | — | CN | claimed |
| US-20250197380-A1 | PHARMACEUTICAL INTERMEDIATE AND SYNTHESIS METHOD, AND ISOQUINOLINE DERIVATIVE AND SYNTHESIS METHOD THEREFOR | BANGENTAI(SHANDONG) BIOSCIENCES GROUP SHARE CO., LTD. (CN) | 2025-06-19 | — | — | US | claimed |
| EP-4568953-A1 | METHODS AND PROCESSES FOR THE PREPARATION OF MCT4 INHIBITORS | Vettore, LLC (US) | 2025-06-18 | — | — | EP | claimed |
| WO-2025123046-A1 | SYNTHESIS OF LEUCINE-RICH REPEAT KINASE 2 MODULATORS | ARVINAS OPERATIONS, INC. (US) | 2025-06-12 | — | — | WO | claimed |
| CN-119912339-A | In the ilast group Process for the preparation of intermediates | 浙江天宇药业股份有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-119751326-A | Method for high-throughput synthesis of 1-phenyl azetidine compounds | 上海泓博尚奕药物技术有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-112442060-B | Method for synthesizing gamma-aminoborate by copper catalysis | 江苏海洋大学 | 2025-04-01 | — | — | CN | claimed |
| CN-114591273-A | Synthesis method and application of N-methyl-N' -tetrahydrofuran formyl propane diamine oxalate | 邦恩泰(山东)生物医药科技集团股份有限公司 | 2022-06-07 | — | — | CN | claimed |
| CN-114573569-A | Preparation method of isoquinoline compounds | 邦恩泰(山东)生物医药科技集团股份有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-114573506-A | Drug intermediate and synthetic method thereof, isoquinoline derivative and synthetic method thereof | 邦恩泰(山东)生物医药科技集团股份有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-110331447-B | Method for preparing On-DNA aryl alkyne compound in construction of DNA coding compound library | 上海药明康德新药开发有限公司 | 2022-05-27 | — | — | CN | claimed |
| WO-2022103990-A1 | METHODS OF MODIFYING PHOSPHORYLATED OR SULFATED TYROSINE RESIDUES OF POLYPEPTIDES | PHOSFISH LLC (US) | 2022-05-19 | — | — | WO | claimed |
| CN-114502558-A | Method for preparing activin receptor-like kinase inhibitors | 缆图药品公司 | 2022-05-13 | — | — | CN | claimed |
| CN-113548968-B | Method for synthesizing (Z) -olefin by nickel-catalyzed iron-mediated alkyne fluoroalkyl and product | 南京工业大学 | 2022-05-03 | — | — | CN | claimed |
| CN-114423764-A | Intermediate, preparation method and application thereof | 四川大学 | 2022-04-29 | — | — | CN | claimed |
| US-20220127251-A1 | PROCESS FOR THE PRODUCTION OF ARYLAMINES | MERCK PATENT GMBH (DE) | 2022-04-28 | — | — | US | claimed |
| US-20220106278-A1 | REAGENTS AND METHODS FOR TETRAZINE SYNTHESIS | UNIVERSITY OF DELAWARE (US) | 2022-04-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127251-A1 | PROCESS FOR THE PRODUCTION OF ARYLAMINES | MAOB, TYR, INMT | ALDH1A1 777/4885MEN1 2585/4885KMT2A 134/4885 |
| US-20250388564-A1 | METHODS OF MANUFACTURING PYRIDAZINONE COMPOUNDS | MUSK, SMN1; SMN2, PAX3 | ALDH1A1 469/4885MEN1 2646/4885KMT2A 2302/4885 |
| US-20220106278-A1 | REAGENTS AND METHODS FOR TETRAZINE SYNTHESIS | TST, CYP4F8, CYP4Z1 | ALDH1A1 874/4885MEN1 2411/4885KMT2A 1657/4885 |
| US-20250197380-A1 | PHARMACEUTICAL INTERMEDIATE AND SYNTHESIS METHOD, AND ISOQUINOLINE DERIVATIVE AND SYNTHESIS METHOD THEREFOR | PARK7, SQLE, CYP4F11 | ALDH1A1 951/4885MEN1 1406/4885KMT2A 2510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.